Deborah Watkins Bruner, RN, PhD presented  "Hypofractionated RT Can Reduce Treatment Time by One-third with Comparable QOL for Prostate Cancer Patients" at ASTRO Annual Meeting. View the slides

Bradley R. Prestidge, MD, MS presented "Intermediate Risk Prostate Cancer May be Well Controlled with Brachytherapy Alone" at ASTRO Annual Meeting. View the slides

Intensity Modulated Radiation Therapy Associated with Reduction in Patient Reported Xerostomia in Head and Neck Cancer Patients. Read more

IDH and CIC Mutations Provide Prognostic Information for Grade II and III Gliomas. Read more

The Addition of External Beam Therapy to Brachytherapy Does Not Produce Superior Progression-Free Survival Results for Intermediate Risk Prostate Cancer Patients. Read more

Shortened Radiation Therapy Schedule Effective in Patients with Low-Risk Prostate Cancer. Read more

Intensity Modulated Pelvic Radiation Therapy Reduces Patient Reported Toxicities. Read more

Stereotactic Body Radiation Therapy Found Safe for Medically Inoperable Patients with Non-Small Cell Lung Cancer. Read more

NRG Oncology Newsletter Volume 2 2016 is now available. Read more

The Blue Ribbon Panel presents its report to the National Cancer Advisory Board on September 7, 2016. The report describes ten transformative research recommendations for acheiving the Cancer Moonshot's goal. Read more

The schedule of NRG Oncology's presentations at the 2016 ASTRO Annual Meeting in Boston has been released. Read more

Gynecologic Oncology Group Protocol 240 - Three Years After. Read more

Let us know how our Communications Committee is doing! Fill out our survey to provide us with feedback regarding NRG Oncology's newsletter, website, and other communications. Read more

Thomas B. Julian, MD, named an NRG Oncology deputy chair, chair of the NRG Oncology Communications Committee and co-chair of the NRG Oncology Publications Committee. Read more

Walter J. Curran Jr., MD, a NRG Oncology Group Chair, was recently interviewed regarding adjuvant temozolomide in elderly patients with glioblastoma at ASCO. Read more 

NRG Oncology Group Chair Dr. Wolmark nominated for Giants of Cancer Care® award Read more

RTOG 0617 Shows Survival Correlation for Low versus High Enrolling Institutions for Patients with LA-NSCLC. Read more

NRG Oncology at ASCO 2016. Read more​

Promising survival outcomes for primary CNS lymphoma patients treated with Rituximab, Chemotherapy, and Radiation. Read more

GOG-0237 Study News.  Read more ​

NRG Oncology Group Chair Dr. Curran receives ACR Gold Medal Award.  Read more ​